Category:Hedgehog pathway inhibitors

From HemOnc.org - A Hematology Oncology Wiki
Jump to: navigation, search

A class of drugs that target one or more components of the Hedgehog signaling pathway. Vismodegib is the first in class to be FDA approved.

Subcategories

This category has only the following subcategory.

Pages in category "Hedgehog pathway inhibitors"

The following 3 pages are in this category, out of 3 total.